{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Paliperidone+palmitate&page=2", "query": { "intervention": "Paliperidone palmitate", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 49, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Paliperidone+palmitate&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Paliperidone+palmitate&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T14:28:32.060Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01411085", "title": "Risperidone and Desipramine in Alcohol Use and Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia", "Alcoholism", "Dual Diagnosis" ], "interventions": [ { "name": "Risperidone + Desipramine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2011-12", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2018-03-23", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 4, "location_summary": "Worcester, Massachusetts • Grand Rapids, Michigan • Lebanon, New Hampshire + 1 more", "locations": [ { "city": "Worcester", "state": "Massachusetts" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01411085" }, { "nct_id": "NCT02087579", "title": "Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psychotic Disorders", "Schizophrenia", "Bipolar Disorder", "Depressive Disorder" ], "interventions": [ { "name": "Aripiprazole, oral formulation", "type": "DRUG" }, { "name": "Olanzapine, oral formulation", "type": "DRUG" }, { "name": "Paliperidone, oral formulation", "type": "DRUG" }, { "name": "Paliperidone, LAI", "type": "DRUG" }, { "name": "Quetiapine, oral formulation", "type": "DRUG" }, { "name": "Risperidone, oral formulation", "type": "DRUG" }, { "name": "Risperidone, LAI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 305, "start_date": "2014-02", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-10-29", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 6, "location_summary": "Garden Grove, California • Kissimmee, Florida • Atlanta, Georgia + 3 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Hoffman Estates", "state": "Illinois" }, { "city": "Cedarhurst", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02087579" }, { "nct_id": "NCT00590577", "title": "Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Paliperidone palmitate 25 mg eq.", "type": "DRUG" }, { "name": "Paliperidone palmitate 150 mg eq.", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Paliperidone palmitate 100 mg eq.", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 652, "start_date": "2007-03", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2014-06-04", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 32, "location_summary": "Anaheim, California • Cerritos, California • Escondido, California + 29 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "La Palma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00590577" }, { "nct_id": "NCT02431702", "title": "A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia", "Psychotic Disorders" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Oral Paliperidone ER", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Oral Risperidone", "type": "DRUG" }, { "name": "Paliperidone Palmitate Injection (PP1M)", "type": "DRUG" }, { "name": "Paliperidone Palmitate Injection (PP3M)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 337, "start_date": "2015-07-08", "completion_date": "2019-11-12", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Garden Grove, California • Lemon Grove, California + 31 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02431702" }, { "nct_id": "NCT00524043", "title": "An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Paliperidone ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2007-09", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2014-06-04", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 12, "location_summary": "Cerritos, California • Torrance, California • Washington D.C., District of Columbia + 9 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Leesburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00524043" }, { "nct_id": "NCT05321602", "title": "Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia", "Psychotic Disorders", "Mood Disorders", "Schizophrenia Spectrum and Other Psychotic Disorders", "Mental Disorders", "Antipsychotic Agents", "Tranquilizing Agents", "Central Nervous System Depression", "Physiological Effects of Drugs", "Psychotropic Drugs", "Neurotransmitter Agents", "Molecular Mechanisms of Pharmacological Action" ], "interventions": [ { "name": "LY03010 156 mg treatment group, deltoid", "type": "DRUG" }, { "name": "LY03010 156 mg treatment group, gluteal", "type": "DRUG" }, { "name": "LY03010 351 mg treatment group, deltoid", "type": "DRUG" }, { "name": "LY03010 351 mg treatment group, gluteal", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Luye Pharma Group Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 89, "start_date": "2021-09-08", "completion_date": "2022-10-23", "has_results": false, "last_update_posted_date": "2024-03-19", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 9, "location_summary": "Little Rock, Arkansas • Garden Grove, California • Orange, California + 6 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05321602" }, { "nct_id": "NCT00766064", "title": "Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Posttraumatic Stress Disorder" ], "interventions": [ { "name": "Paliperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2008-09", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2016-08-23", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00766064" }, { "nct_id": "NCT00592358", "title": "Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pediatric Bipolar Disorder" ], "interventions": [ { "name": "paliperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 17, "start_date": "2007-11", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2012-07-04", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 1, "location_summary": "Cambridge, Massachusetts", "locations": [ { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00592358" }, { "nct_id": "NCT02085447", "title": "A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psychotic Disorders", "Schizophrenia", "Schizoaffective Disorder", "Medication Adherence", "Medication Non-Adherence" ], "interventions": [ { "name": "CAE-L", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2014-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-12-09", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02085447" }, { "nct_id": "NCT04572685", "title": "Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia Patients" ], "interventions": [ { "name": "Paliperidone Palmitate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Luye Pharma Group Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 36, "start_date": "2020-01-22", "completion_date": "2020-08-20", "has_results": false, "last_update_posted_date": "2020-11-09", "last_synced_at": "2026-09-30T14:28:32.060Z", "location_count": 1, "location_summary": "Berlin, New Jersey", "locations": [ { "city": "Berlin", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04572685" } ] }